| ISIN | CH0117043700 |
|---|---|
| Valor Number | 11704370 |
| Bloomberg Global ID | BBG001DCNBP9 |
| Fund Name | Swisscanto (CH) Index Equity Fund Switzerland Total (I) NT CHF |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 261.36 CHF | 31.10.2025 |
|---|---|---|
| Previous Price * | 262.61 CHF | 30.10.2025 |
| 52 Week High * | 268.58 CHF | 16.10.2025 |
| 52 Week Low * | 224.81 CHF | 09.04.2025 |
| NAV * | 261.36 CHF | 31.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 3,907,224,663 | |
| Unit/Share Assets *** | 3,466,304,955 | |
| Trading Information SIX | ||
| YTD Performance | +9.75% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
|---|---|---|
| 1 month | +1.40% |
30.09.2025 - 31.10.2025
30.09.2025 31.10.2025 |
| 3 months | +2.77% |
31.07.2025 - 31.10.2025
31.07.2025 31.10.2025 |
| 6 months | +3.05% |
30.04.2025 - 31.10.2025
30.04.2025 31.10.2025 |
| 1 year | +8.07% |
31.10.2024 - 31.10.2025
31.10.2024 31.10.2025 |
| 2 years | +24.72% |
31.10.2023 - 31.10.2025
31.10.2023 31.10.2025 |
| 3 years | +23.04% |
31.10.2022 - 31.10.2025
31.10.2022 31.10.2025 |
| 5 years | +39.08% |
02.11.2020 - 31.10.2025
02.11.2020 31.10.2025 |
| Equity Participation Rate in % | 94.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 13.1075 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 31.10.2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.26% | |
|---|---|---|
| Nestle SA | 11.74% | |
| Roche Holding AG | 11.38% | |
| UBS Group AG Registered Shares | 6.04% | |
| ABB Ltd | 5.64% | |
| Zurich Insurance Group AG | 5.17% | |
| Compagnie Financiere Richemont SA Class A | 5.08% | |
| Swiss Re AG | 2.74% | |
| Lonza Group Ltd | 2.31% | |
| Holcim Ltd | 2.22% | |
| Last data update | 30.09.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 28.02.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.00% |
| Ongoing Charges *** | 0.01% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |